Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Harvard Business School
US Department of Justice
Boehringer Ingelheim
Fuji
Mallinckrodt
US Army
Dow

Generated: May 26, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,670,335

« Back to Dashboard

Which drugs does patent 6,670,335 protect, and when does it expire?

Patent 6,670,335 protects CARAC and is included in one NDA.
Summary for Patent: 6,670,335
Title: Fluorouracil-containing formulation
Abstract:Oil-in-water emulsion formulations contain both free fluorouracil and fluorouracil impregnated in porous microparticles. The formulations are suitable for topical administration, and are useful for the treatment of solar keratoses, actinic keratoses, and superficial basal cell carcinomas.
Inventor(s): Singh; B. Sandhya (San Jose, CA), Saxena; Subhash J. (Belmont, CA)
Assignee: A. P. Pharma, Inc. (Redwood City, CA)
Application Number:09/799,792
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,670,335
Patent Claim Types:
see list of patent claims
Formulation; Use; Dosage form;

Drugs Protected by US Patent 6,670,335

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Valeant Pharms North CARAC fluorouracil CREAM;TOPICAL 020985-001 Oct 27, 2000 AB RX Yes Yes ➤ Sign Up ➤ Sign Up Y TREATMENT OF ACTINIC KERATOSIS ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
US Army
Julphar
Fuji
Argus Health
Citi
Moodys
Chinese Patent Office
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.